Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists
VCEL

VCEL - Vericel Corp Stock Price, Fair Value and News

43.27USD-0.25 (-0.57%)Market Closed

Market Summary

VCEL
USD43.27-0.25
Market Closed
-0.57%

VCEL Alerts

  • 2 major insider sales recently.
  • Big jump in Revenue (Y/Y)
  • Big jump in Earnings (Y/Y)
  • Losses in recent quarter

VCEL Stock Price

View Fullscreen

VCEL RSI Chart

VCEL Valuation

Market Cap

2.1B

Price/Earnings (Trailing)

4.7K

Price/Sales (Trailing)

10.12

EV/EBITDA

130.16

Price/Free Cashflow

1.0K

VCEL Price/Sales (Trailing)

VCEL Profitability

EBT Margin

4.92%

Return on Equity

0.19%

Return on Assets

0.13%

Free Cashflow Yield

0.1%

VCEL Fundamentals

VCEL Revenue

Revenue (TTM)

207.8M

Rev. Growth (Yr)

25.02%

Rev. Growth (Qtr)

-21.1%

VCEL Earnings

Earnings (TTM)

451.0K

Earnings Growth (Yr)

48.47%

Earnings Growth (Qtr)

-129.72%

Breaking Down VCEL Revenue

Last 7 days

-7.1%

Last 30 days

-10.3%

Last 90 days

-1.6%

Trailing 12 Months

27.3%

How does VCEL drawdown profile look like?

VCEL Financial Health

Current Ratio

5.2

Debt/Equity

0.06

Debt/Cashflow

2.63

VCEL Investor Care

Shares Dilution (1Y)

2.18%

Diluted EPS (TTM)

0.01

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024207.8M000
2023169.3M178.2M185.2M197.5M
2022157.7M155.2M159.3M164.4M
2021132.1M151.6M153.8M156.2M
2020122.7M116.6M118.3M124.2M
201994.6M101.8M109.8M117.8M
201872.6M74.6M82.9M90.9M
201756.5M60.6M63.9M63.9M
201654.4M53.7M53.3M61.2M
201539.6M48.8M50.5M51.2M
2014017.3M23.0M28.8M
201327.0K30.0K5.8M11.5M
201211.0K11.0K2.0K21.0K
201153.5K41.7K29.8K18.0K
2010089.0K77.2K65.3K
20090182.0K00

Tracking the Latest Insider Buys and Sells of Vericel Corp

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Jun 03, 2024
wright lisa
acquired
-
-
434
-
May 20, 2024
hopper jonathan mark
sold
-499,900
49.99
-10,000
chief medical officer
May 20, 2024
hopper jonathan mark
acquired
109,500
10.95
10,000
chief medical officer
May 17, 2024
halpin michael
acquired
28,017
5.39314
5,195
chief operating officer
May 16, 2024
colangelo dominick
sold
-837,375
47.85
-17,500
president and ceo
May 16, 2024
colangelo dominick
acquired
52,850
3.02
17,500
president and ceo
May 15, 2024
colangelo dominick
sold
-869,225
49.67
-17,500
president and ceo
May 15, 2024
colangelo dominick
acquired
52,850
3.02
17,500
president and ceo

1–10 of 50

Which funds bought or sold VCEL recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Jun 04, 2024
DekaBank Deutsche Girozentrale
unchanged
-
15,000
48,000
-%
Jun 03, 2024
Kopp LeRoy C
new
-
23,805,000
23,805,000
13.60%
May 28, 2024
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
unchanged
-
240,000
763,000
0.01%
May 21, 2024
China Universal Asset Management Co., Ltd.
added
68.16
285,954
482,954
0.06%
May 17, 2024
Plato Investment Management Ltd
new
-
10,300
10,300
-%
May 16, 2024
CASTLEARK MANAGEMENT LLC
reduced
-12.01
1,504,610
6,775,600
0.28%
May 16, 2024
Pineridge Advisors LLC
sold off
-100
-21,046
-
-%
May 16, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-5.4
655,152
2,370,340
-%
May 16, 2024
Beacon Capital Management, LLC
new
-
572
572
-%
May 16, 2024
JANE STREET GROUP, LLC
added
21.15
230,467
529,876
-%

1–10 of 46

Are Funds Buying or Selling VCEL?

Are funds buying VCEL calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own VCEL
No. of Funds

Unveiling Vericel Corp's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
brown capital management llc
14.29%
6,818,933
SC 13G/A
Feb 14, 2024
rtw investments, lp
6.7%
3,212,794
SC 13G/A
Feb 13, 2024
vanguard group inc
7.07%
3,374,093
SC 13G/A
Jan 25, 2024
state street corp
5.58%
2,664,883
SC 13G/A
Jan 22, 2024
blackrock inc.
16.6%
7,937,063
SC 13G/A
Jan 05, 2024
conestoga capital advisors, llc
5.23%
2,495,619
SC 13G/A
Feb 14, 2023
brown capital management llc
14.68%
6,931,641
SC 13G/A
Feb 14, 2023
rtw investments, lp
6.6%
3,099,904
SC 13G/A
Feb 09, 2023
state street corp
7.12%
3,364,203
SC 13G/A
Feb 09, 2023
vanguard group inc
7.00%
3,307,928
SC 13G/A

Recent SEC filings of Vericel Corp

View All Filings
Date Filed Form Type Document
Jun 12, 2024
144
Notice of Insider Sale Intent
Jun 05, 2024
4
Insider Trading
May 21, 2024
4
Insider Trading
May 21, 2024
4
Insider Trading
May 20, 2024
144
Notice of Insider Sale Intent
May 17, 2024
4
Insider Trading
May 16, 2024
144
Notice of Insider Sale Intent
May 15, 2024
144
Notice of Insider Sale Intent
May 08, 2024
10-Q
Quarterly Report
May 08, 2024
8-K
Current Report

Peers (Alternatives to Vericel Corp)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
55.6B
6.8B
17.55% 15.42%
-9.32
8.12
-64.45% -224.75%
22.5B
216.3K
-0.77% 465779.94%
-2.5K
104.0K
- -8.13%
20.2B
2.0B
6.10% -19.49%
-60.95
10.1
75.20% 68.82%
16.0B
2.5B
5.03% -10.77%
77.84
6.47
13.74% 186.89%
14.1B
3.8B
4.06% -3.24%
18.89
3.74
8.58% 129.81%
MID-CAP
5.4B
107.9M
0.63% 71.22%
-9.93
48.09
54.84% -28.31%
5.2B
524.1M
-1.19% -54.45%
-12.36
9.84
394.93% 39.61%
3.4B
251.0M
-5.41% -4.45%
-11.62
13.72
73.58% -86.73%
3.3B
240.7M
16.82% -26.89%
-6.96
12.77
-1.03% -213.92%
2.5B
813.8M
1.25% -38.59%
-1.5K
3.07
56.43% 98.83%
2.1B
996.6M
20.98% 97.26%
-5.3
2.12
-26.66% 65.49%
SMALL-CAP
1.8B
411.3M
-4.75% 32.39%
27.77
4.4
60.38% -34.49%
564.4M
881.7K
19.55% 492.49%
-16.72
481.06
-77.61% 33.36%
244.6M
4.2M
-16.55% 51.92%
-1.96
58.8
-66.30% 48.24%
22.1M
2.1M
40.11% 239.32%
-0.95
7.61
-13.45% 69.54%

Vericel Corp News

Latest updates
Defense World13 hours ago
Insider Monkey21 May 202407:00 am
Seeking Alpha08 May 202407:00 am

Vericel Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue-21.1%51,28164,99645,58145,92241,01752,69438,55137,04636,07447,59134,50639,51934,56845,22932,25820,01426,67839,39030,49926,15121,810
Gross Profit-27.1%35,35448,50730,60829,94126,52038,24925,23322,85423,45234,03222,09826,91022,98533,64722,47111,35416,75628,80521,17517,12913,170
Operating Expenses14.1%40,81835,77635,66535,90234,69732,16432,02131,93630,72529,89127,05930,63926,29021,35818,95419,71221,83219,59518,07837,32916,528
  S&GA Expenses11.4%34,40030,87529,98930,64929,48526,91926,97527,14425,86525,96722,77526,19022,66018,24016,04116,48618,06916,37814,98216,25913,520
  R&D Expenses31.0%6,4184,9015,6765,2535,2125,2455,0464,7924,8603,9244,2844,4493,6303,1182,9133,2263,7633,2173,09621,0703,008
EBITDA Margin-3.5%0.08*0.08*-0.04*-0.06*-0.07*-0.07*-0.09*-0.09*-0.05*-0.03*0.02*0.08*---------
Interest Expenses-1.9%15315615014914522310520.0018.001.001.001.001.001.002.001.002.002.002.002.002.00
Income Taxes-100.0%-1,100-286--70021.00---326-72.00143180-------
Earnings Before Taxes-100.0%-14,093-3,946--6,622-6,556-8,963-7,0914,209-4,931-3,714-3,14612,4003,618-8,269-4,705----
EBT Margin-4.9%0.05*0.05*-0.07*-0.09*-0.09*-0.10*-0.12*-0.11*-0.07*-0.05*0.00*0.06*---------
Net Income-129.7%-3,86212,993-3,660-5,020-7,4955,922-6,577-8,963-7,0914,535-4,931-3,786-3,28912,2203,618-8,269-4,7059,5013,470-19,792-2,844
Net Income Margin113.5%0.00*-0.02*-0.06*-0.07*-0.10*-0.10*-0.11*-0.11*-0.07*-0.05*0.00*0.06*---------
Free Cashflow-402.8%-6,8152,2516006,0006,4475,8502,6921,1623879,5601,1712,651---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets0.8%357354318311265273248245240244224222211206158147150153138126141
  Current Assets-7.7%19020618618317818716615515215814513912712412511611711210594.00110
    Cash Equivalents-8.9%63.0069.0060.0043.0062.0051.0065.0056.0056.0068.0055.0052.0058.0034.0044.0056.0046.0027.0037.0014.0035.00
  Inventory3.6%14.0013.0013.0014.0015.0016.0017.0016.0014.0013.0013.0013.0010.009.0010.008.007.007.007.005.004.00
  Net PPE-------------------7.007.006.00
Liabilities-3.9%12312811411271.0081.0070.0070.0068.0073.0067.0071.0071.0071.0043.0039.0040.0042.0041.0037.0038.00
  Current Liabilities-20.3%36.0046.0036.0036.0029.0037.0027.0025.0022.0026.0019.0024.0023.0022.0021.0018.0018.0020.0015.0013.0013.00
Shareholder's Equity3.5%23422620419919419217817517217015715114013411510811011197.0089.00103
  Retained Earnings-0.9%-407-403-416-412-407-399-405-399-390-383-387-382-379-375-388-391-383-378-388-391-371
Shares Outstanding1.4%48.0048.0048.0048.0047.0047.0047.0047.0047.0046.0046.0046.00---------
Float----1,775---1,179---2,431---618---828-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-28.6%7,20210,0867,16910,1967,8606,9754,1013,1433,46810,5513,6344,76910,08611,3374,570-3,0214,6863,1507,892-18,379154
  Share Based Compensation42.3%9,8346,9097,9248,7618,7317,7409,10410,8089,5317,8418,59610,8667,0193,0242,6754,3763,7683,0843,2854,1822,628
Cashflow From Investing-214.7%-25,452-8,0884,566-2,4082,800-21,729-811-2,997-10,6691,885-2,629-14,94312,186-25,678-17,43612,21213,742-14,60413,368-3,81115,662
Cashflow From Financing62.7%2,1261,3071,0091,195107605-3122495031,3411,7873,7812,2624,4547918903061,5271,6831,068982
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

VCEL Income Statement

2024-03-31
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]  
Product sales, net$ 51,281$ 41,017
Total revenue51,28141,017
Cost of product sales15,92714,497
Gross profit35,35426,520
Research and development6,4185,212
Selling, general and administrative34,40029,485
Total operating expenses40,81834,697
Loss from operations(5,464)(8,177)
Other income (expense):  
Interest income1,762839
Interest expense(153)(145)
Other expense(7)(12)
Total other income1,602682
Net loss$ (3,862)$ (7,495)
Net loss per common share:  
Basic (in USD per share)$ (0.08)$ (0.16)
Diluted (in USD per share)$ (0.08)$ (0.16)
Weighted-average common shares outstanding:  
Basic (in shares)48,14147,387
Diluted (in shares)48,14147,387
Revenue, Product and Service [Extensible List]Product [Member]Product [Member]
Cost, Product and Service [Extensible List]Product [Member]Product [Member]

VCEL Balance Sheet

2024-03-31
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:  
Cash and cash equivalents$ 62,938$ 69,088
Restricted cash7,80417,778
Short-term investments47,71040,469
Accounts receivable (net of allowance for doubtful accounts of $87 and $43, respectively)49,93458,356
Inventory13,55713,087
Other current assets7,7756,853
Total current assets189,718205,631
Property and equipment, net56,39241,635
Intangible assets, net6,7196,875
Right-of-use assets73,68273,462
Long-term investments29,43325,283
Other long-term assets717771
Total assets356,661353,657
Current liabilities:  
Accounts payable19,43222,347
Accrued expenses11,02617,215
Current portion of operating lease liabilities6,0126,187
Total current liabilities36,47045,749
Operating lease liabilities86,14181,856
Other long-term liabilities154100
Total liabilities122,765127,705
COMMITMENTS AND CONTINGENCIES (Note 12)
Shareholders’ equity:  
Common stock, no par value; shares authorized — 75,000; shares issued and outstanding — 48,489 and 47,829, respectively641,180629,229
Accumulated other comprehensive loss(245)(100)
Accumulated deficit(407,039)(403,177)
Total shareholders’ equity233,896225,952
Total liabilities and shareholders’ equity$ 356,661$ 353,657
VCEL
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product is NexoBrid, a biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.
 CEO
 WEBSITEhttps://vcel.com
 INDUSTRYBiotechnology
 EMPLOYEES305

Vericel Corp Frequently Asked Questions


What is the ticker symbol for Vericel Corp? What does VCEL stand for in stocks?

VCEL is the stock ticker symbol of Vericel Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Vericel Corp (VCEL)?

As of Wed Jun 12 2024, market cap of Vericel Corp is 2.12 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of VCEL stock?

You can check VCEL's fair value in chart for subscribers.

What is the fair value of VCEL stock?

You can check VCEL's fair value in chart for subscribers. The fair value of Vericel Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Vericel Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for VCEL so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Vericel Corp a good stock to buy?

The fair value guage provides a quick view whether VCEL is over valued or under valued. Whether Vericel Corp is cheap or expensive depends on the assumptions which impact Vericel Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for VCEL.

What is Vericel Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Jun 12 2024, VCEL's PE ratio (Price to Earnings) is 4.69 Thousand and Price to Sales (PS) ratio is 10.18. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. VCEL PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Vericel Corp's stock?

In the past 10 years, Vericel Corp has provided 0.263 (multiply by 100 for percentage) rate of return.